ASH may discontinue the Program at any time upon advance written notice
September 2024 : Aurinia Pharmaceuticals received approval for voclosporin (LUPKYNIS) from the Japanese Ministry of Health, Labour, and Welfare for the treatment of lupus nephritis (LN) in combination with mycophenolate mofetil (MMF)
GLP-1 receptors sit in the heart muscle itself
Urva, et al., LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept, 2022, Cell Metabolism 34, 12341247
Commonly Studied with TB-500 BPC-157 is frequently researched alongside TB-500 due to their complementary biological profiles